mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.8 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |